Prime Medicine, Inc. Common Stock (PRME): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 7,296 US Dollar | 10 | 1 | 3 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 181.376.856 | 23,17 | 6,8 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Prime Medicine, Inc. Common Stock
Mitarbeiter 146
Handelsplatz NASDAQ
Ticker Symbol PRME
IPO Datum 2022-10-20
Adresse 60 First Street, Cambridge, MA, United States, 02141
Webseite https://primemedicine.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Jeffrey D. Marrazzo M.B.A., M.P.A. | Executive Chair |
| 2 | Dr. Allan Reine M.D. | CEO & Director |
| 3 | Dr. Ann L. Lee Ph.D. | Chief Technical Officer |
| 4 | Dr. Andrew Anzalone M.D., Ph.D. | Co-Founder & Head of Platform |
| 5 | Dr. David R. Liu Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| 6 | Ms. Svetlana Makhni | Chief Financial Officer |
| 7 | Mr. Ryan E. Brown J.D. | Chief Legal Officer |
| 8 | Ms. Niamh Alix | Chief Human Resources Officer |
| 9 | Mr. Mohammed Asmal M.D., Ph.D. | Chief Medical Officer |
| 10 | Dr. Matthew J. Hawryluk M.B.A., Ph.D. | Chief Business Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Alphabet Inc | 9,13% | 86,79 Mio. USD |
| 2 | BlackRock Inc | 5,29% | 50,32 Mio. USD |
| 3 | ARK Investment Management LLC | 4,60% | 43,75 Mio. USD |
| 4 | State Street Corp | 4,18% | 39,70 Mio. USD |
| 5 | T. Rowe Price Investment Management,Inc. | 2,89% | 27,44 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 2,49% | 23,70 Mio. USD |
| 7 | Balyasny Asset Management LLC | 2,19% | 20,80 Mio. USD |
| 8 | The Goldman Sachs Group Inc | 1,89% | 17,98 Mio. USD |
| 9 | Casdin Capital, LLC | 1,75% | 16,60 Mio. USD |
| 10 | Woodline Partners LP | 1,66% | 15,74 Mio. USD |
| 11 | UBS Group AG | 1,54% | 14,64 Mio. USD |
| 12 | Geode Capital Management, LLC | 1,50% | 14,21 Mio. USD |
| 13 | Sumitomo Mitsui Trust Group Inc | 1,33% | 12,64 Mio. USD |
| 14 | Amova Asset Management Americas, Inc | 1,33% | 12,61 Mio. USD |
| 15 | Citadel Advisors Llc | 1,13% | 10,77 Mio. USD |
| 16 | ADAR1 Capital Management LLC | 1,10% | 10,47 Mio. USD |
| 17 | FMR Inc | 0,97% | 9,23 Mio. USD |
| 18 | Two Sigma Investments LLC | 0,84% | 7,99 Mio. USD |
| 19 | Redmile Group, LLC | 0,77% | 7,28 Mio. USD |
| 20 | Farallon Capital Management, L.L.C. | 0,68% | 6,50 Mio. USD |